Recruiting

Defining the Role of Palliative carE for Patients With Hematologic Malignancies Undergoing Adoptive CEllular Therapy

Sponsor:

Massachusetts General Hospital

Code:

NCT05646576

Conditions

Hematologic Malignancy

Blood Cancer

Lymphoma

Leukemia

Multiple Myeloma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Palliative Care

Usual Care

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-31. This information was provided to ClinicalTrials.gov by Massachusetts General Hospital on 2024-05-29.